Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 2.800
0.00 (0.00%)
Sep 17, 2026, 9:50 AM CET
Arctic Bioscience AS Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -40.1 | -41.03 | -47.93 | -45.51 | -34.02 | -42.58 |
Depreciation & Amortization | 1.66 | 2.86 | 5.15 | 5.38 | 3.73 | 2.52 |
Other Amortization | 3.11 | 2.26 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | -0.01 | -0.01 | - | - | - |
Other Operating Activities | 0 | 0 | - | - | -0 | - |
Change in Accounts Receivable | -0.49 | 4.37 | -5 | 3.91 | -5.77 | 3.3 |
Change in Inventory | -2.92 | -0.64 | 3.81 | 2.67 | -6.94 | -2.28 |
Change in Accounts Payable | 15.09 | 10.47 | -0.78 | 2.82 | 9.89 | -1.57 |
Change in Other Net Operating Assets | 5.1 | -0.94 | -0.58 | 0.37 | 7.71 | 1.12 |
Operating Cash Flow | -18.54 | -22.65 | -45.36 | -30.37 | -25.4 | -39.49 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6.86 | -22.75 | -50.81 | -34.7 | -58.57 | -36.5 |
Sale of Property, Plant & Equipment | - | 0.05 | 0.18 | 2.23 | - | - |
Investing Cash Flow | -8.14 | -22.7 | -50.63 | -32.47 | -58.57 | -36.5 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 43.99 | 20.24 | - | - | - |
Total Debt Issued | 24.98 | 43.99 | 20.24 | - | - | - |
Short-Term Debt Repaid | - | - | - | - | - | -1.88 |
Long-Term Debt Repaid | - | -0.63 | -0.58 | -2.2 | - | -6.58 |
Total Debt Repaid | -0.66 | -0.63 | -0.58 | -2.2 | - | -8.45 |
Net Debt Issued (Repaid) | 24.32 | 43.36 | 19.66 | -2.2 | - | -8.45 |
Issuance of Common Stock | - | - | - | 0.49 | 0.75 | 299.21 |
Financing Cash Flow | 24.32 | 43.36 | 19.66 | -1.71 | 0.75 | 290.76 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -2.36 | -1.99 | -76.32 | -64.55 | -83.21 | 214.76 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -25.39 | -45.4 | -96.17 | -65.07 | -83.96 | -76 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -51.86% | -106.53% | -216.64% | -192.81% | -243.58% | -353.22% |
Free Cash Flow Per Share | -0.94 | -1.68 | -3.79 | -2.56 | -3.43 | -3.12 |
Levered Free Cash Flow | -16.22 | -36.09 | -69.45 | -60.47 | -71.64 | -58.59 |
Unlevered Free Cash Flow | -10.31 | -30.41 | -67.48 | -59.85 | -71.64 | -58.38 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 16.79 | 13.26 | -2.56 | 9.76 | 4.9 | 0.57 |